News on the latest health tech of Asian markets
Heart and brain disease AI market – ShuKun completed 200 million B round of...
On February 18, 2019, the medical artificial intelligence company ShuKun announced the completion of the 200 million yuan B round of financing. The investment...
C Stone Pharma plans to land on HKEx and raise more than HK$2 billion
C Stone Pharma (02616.HK), headquartered in Suzhou, announced the pricing of its initial public offering (IPO) on the Hong Kong Stock Exchange (HKSE). The...
Burning Rock Dx completes C round 850 million RMB financing
On February 14, 2019, Burning Rock Dx held a C-round financing signing ceremony and officially announced that it has received a total of RMB...
Sciwind Biosciences wins nearly 200 million RMB financing in round A
Hangzhou Sciwind Biosciences completed the financing of nearly RMB 200 million in the A round, led by Legend Capital, and the existing shareholders ShiYu...
Gene editing company EdiGene completes 70 million RMB Pre-B+ round financing
Gene editing company EdiGene announced the completion of the Pre-B+ round of approximately RMB 70 million in financing; at the same time, Dr. Li...